A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome
β Scribed by James A. Sloand; Mark A. Shelly; Andrew Feigin; Paul Bernstein; Rebeca D. Monk
- Book ID
- 114466542
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 69 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0272-6386
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Iron deficiency may exacerbate symptoms in the Restless Legs Syndrome (RLS). We investigated the effect of intravenous iron sucrose or placebo on symptoms in patients with RLS and mild to moderate iron deficit. Sixty patients with primary RLS (seven males, age 46 (9) years, Sβferritin β€
A double-blind randomized crossover study of 7.5 mg bromocriptine at bedtime versus placebo was conducted in 30-day phases (with a 2-week washout period between phases) in 6 patients with idiopathic restless legs syndrome. Five patients experienced partial subjective improvement in restlessness and